Transcriptomics

Dataset Information

0

Anti-tumor effects of the eIF4A Inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas


ABSTRACT: Inhibition of translation initiation using eIF4A inhibitors like (-)-didesmethylrocaglamide [(-)-DDR] and (-)-rocaglamide [(-)-Roc] is a potential cancer treatment strategy as they simultaneously diminish multiple oncogenic drivers. We showed that human and dog osteosarcoma cells expressed high levels of eIF4A1/2, which are important for cell growth. To advance preclinical development of eIF4A inhibitors, the importance of (-)-chirality in DDR for growth-inhibitory activity was demonstrated. Bromination of DDR at carbon-5 abolished growth-inhibitory activity, while acetylating DDR at carbon-1 was tolerated. Like DDR and Roc, DDR-acetate increased the γH2A.X levels and induced G2/M arrest and apoptosis. These rocaglates decreased the levels of several mitogenic kinases, the STAT3 transcription factor, and the stress-activated protein kinase p38. However, phosphorylated p38 was greatly enhanced, implying activation of stress response pathways. Importantly, these rocaglates potently suppressed canine osteosarcoma patient-derived xenografts. These results suggest that these eIF4A inhibitors can be leveraged to treat both human and dog osteosarcomas.

ORGANISM(S): Homo sapiens

PROVIDER: GSE267810 | GEO | 2024/05/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-11-23 | PXD022556 | Pride
2023-02-20 | GSE200060 | GEO
| PRJNA596665 | ENA
| PRJNA315688 | ENA
2016-06-15 | E-GEOD-79392 | biostudies-arrayexpress
2016-06-15 | GSE79392 | GEO
2019-11-26 | GSE134865 | GEO
2016-06-15 | GSE70211 | GEO
2017-07-01 | E-MTAB-1210 | biostudies-arrayexpress
2010-05-08 | E-GEOD-16087 | biostudies-arrayexpress